ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00395174
Recruitment Status : Completed
First Posted : November 2, 2006
Last Update Posted : December 17, 2009
Sponsor:
Information provided by:
Protein Sciences Corporation